News + Filings Transactions
All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
|
|
Dugel Pravin
|
Create: Alert |
All | News | Filings
| Date Filed | Type | Description |
| 07/13/2023 |
4
| Dugel Pravin (President) has filed a Form 4 on IVERIC bio, Inc.|
Txns:
| Disposed/sold 203,035 shares
@ $0
Disposed/sold 8,625 restricted stock units
@ $0
Disposed/sold 50,000 restricted stock units
@ $0
Disposed/sold 37,500 restricted stock units
@ $0
Disposed/sold 70,000 restricted stock units
@ $0
Disposed/sold 27,500 restricted stock units
@ $0
Disposed/sold 300,000 options to buy
@ $3.16, valued at
$948k
Disposed/sold 110,000 options to buy
@ $7.5, valued at
$825k
Disposed/sold 35,000 options to buy
@ $7.17, valued at
$251k
Disposed/sold 100,000 options to buy
@ $14.83, valued at
$1.5M
Disposed/sold 140,000 options to buy
@ $22.57, valued at
$3.2M
|
|
| 05/11/2023 |
4
| Dugel Pravin (President) has filed a Form 4 on IVERIC bio, Inc.|
Txns:
| Exercised 4,312 restricted stock units
@ $0 |
|
| 04/04/2023 |
4
| Dugel Pravin (President) has filed a Form 4 on IVERIC bio, Inc.|
Txns:
| Exercised 50,000 restricted stock units
@ $0 |
|
| 01/04/2023 |
4
| Dugel Pravin (President) has filed a Form 4 on IVERIC bio, Inc.|
Txns:
| Exercised 12,500 restricted stock units
@ $0 |
|
| 12/20/2022 |
4
| Dugel Pravin (President) has filed a Form 4 on IVERIC bio, Inc.|
Txns:
| Exercised 13,750 restricted stock units
@ $0 |
|
| 11/21/2022 |
4
| Dugel Pravin (President) has filed a Form 4 on IVERIC bio, Inc.|
Txns:
| Exercised 8,474 options to buy
@ $10.03, valued at
$85k
|
|
| 05/05/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 04/05/2022 |
4
| Dugel Pravin (President) has filed a Form 4 on IVERIC bio, Inc.|
Txns:
| Exercised 50,000 restricted stock units
@ $0 |
|
| 12/21/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 12/20/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 11/15/2021 |
4
| Dugel Pravin (President) has filed a Form 4 on IVERIC bio, Inc.|
Txns:
| Exercised 4,237 options to buy
@ $1.652, valued at
$7k
|
|
| 07/02/2021 |
4
| Dugel Pravin (Director) has filed a Form 4 on Aerpio Pharmaceuticals, Inc.|
Txns:
| Granted 6,331 shares
@ $1.52, valued at
$9.6k
|
|
| 05/04/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 04/05/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 04/02/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 03/29/2021 |
3/A
| Form 3/A - Initial statement of beneficial ownership of securities: [Amend] |
| 02/03/2021 |
4
| Dugel Pravin (Director) has filed a Form 4 on Aerpio Pharmaceuticals, Inc.|
Txns:
| Granted 17,857 options to buy
@ $1.46, valued at
$26.1k
|
|
| 12/22/2020 |
4
| Dugel Pravin (EVP, Chief Strategy & Business) has filed a Form 4 on IVERIC bio, Inc.|
Txns:
| Granted 110,000 options to buy
@ $7.5, valued at
$825k
Granted 55,000 restricted stock units
@ $0 |
|
| 06/26/2020 |
4
| Dugel Pravin (Director) has filed a Form 4 on Aerpio Pharmaceuticals, Inc.|
Txns:
| Granted 52,144 options to buy
@ $1.22, valued at
$63.6k
|
|
| 06/16/2020 |
3
| Dugel Pravin (EVP, Chief Strategy & Business) has filed a Form 3 on IVERIC bio, Inc. |
| 06/19/2019 |
4
| Dugel Pravin (Director) has filed a Form 4 on Aerpio Pharmaceuticals, Inc.|
Txns:
| Granted 21,400 options to buy
@ $0.96, valued at
$20.5k
|
|
| 11/16/2018 |
4
| Dugel Pravin (Director) has filed a Form 4 on Aerpio Pharmaceuticals, Inc.|
Txns:
| Granted 2,500 options to buy
@ $2.05, valued at
$5.1k
|
|
| 06/22/2018 |
4
| Dugel Pravin (Director) has filed a Form 4 on Aerpio Pharmaceuticals, Inc.|
Txns:
| Granted 21,400 options to buy
@ $4, valued at
$85.6k
|
|
|
|